SCHEMBL6989

SCHEMBL6989

CC(=CCc1c(C)noc1-c1ccc(Br)cc1)Cc1ccc(C(C)C)cc1

nearest known ligand 0.39

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LPAR1 Q92633 3/20 0.37
LPAR2 Q9HBW0 2/20 0.34
LPAR3 Q9UBY5 2/20 0.34
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
FFAR4 Q5NUL3 1/20 0.31
ALDH1A1 P00352 1/20 0.31
EDNRB P24530 1/20 0.31
EDNRA P25101 1/20 0.31
RAB9A P51151 2/20 0.30
NPC1 O15118 1/20 0.30
GPR183 P32249 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7616 0.81 LPAR1 (0.47) LPAR1LPAR2LPAR3CYP2C9FFAR4
SCHEMBL6575 0.78 LPAR1 (0.39) LPAR1LPAR2LPAR3CYP2C9TDP1
SCHEMBL1300 0.71 CYP1A2 (0.40) CYP1A2CYP3A4CYP2C9CYP2C19TDP1
SCHEMBL7556 0.70 MEN1 (0.36) LPAR1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL7557 0.70 MEN1 (0.36) LPAR1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL1683 0.69 CYP1A2 (0.43) CYP1A2CYP3A4CYP2C9CYP2C19TDP1
SCHEMBL1458 0.69 MAOB (0.40) LPAR1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL1406 0.68 LPAR1 (0.40) LPAR1LPAR2LPAR3CYP2C9ALDH1A1
SCHEMBL22257228 0.68 ALDH1A1 (0.44) LPAR1LPAR3CYP1A2CYP3A4CYP2C9
SCHEMBL18597812 0.68 CYP1A2 (0.44) CYP1A2CYP3A4CYP2C9CYP2C19TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483252-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP disclosed
WO-2011041694-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO disclosed